{
    "organizations": [],
    "uuid": "c4df70f4ae565abe3549b8c63ed26c499daf85c0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-arrowhead-begins-dosing-in-phase-1/brief-arrowhead-begins-dosing-in-phase-1-study-of-aro-aat-for-treatment-of-alpha-1-liver-disease-idUSFWN1QU0SD",
    "ord_in_thread": 0,
    "title": "BRIEF-Arrowhead Begins Dosing In Phase 1 Study Of ARO-AAT For Treatment Of Alpha-1 Liver Disease",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 35 AM / in 11 minutes BRIEF-Arrowhead Begins Dosing In Phase 1 Study Of ARO-AAT For Treatment Of Alpha-1 Liver Disease Reuters Staff 1 Min Read   Arrowhead Pharmaceuticals Inc: * ARROWHEAD BEGINS DOSING IN PHASE 1 STUDY OF ARO-AAT FOR TREATMENT OF ALPHA-1 LIVER DISEASE  ",
    "published": "2018-03-12T13:35:00.000+02:00",
    "crawled": "2018-03-12T13:52:06.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "begin",
        "dosing",
        "phase",
        "study",
        "treatment",
        "liver",
        "disease",
        "reuters",
        "staff",
        "min",
        "read",
        "arrowhead",
        "pharmaceutical",
        "inc",
        "arrowhead",
        "begin",
        "dosing",
        "phase",
        "study",
        "treatment",
        "liver",
        "disease"
    ]
}